A
$ Value
$0
Shares
275,000
Price
$0
Filed
Jan 7
Insider
Name
Litten Jason
Title
Chief Medical Officer
CIK
0001909400
Roles
Officer
Transaction Details
Transaction Date
2026-01-02
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
275,000
Footnotes
The shares subject to the option will vest 25% on the first anniversary of the grant date, and the remaining shares will vest in 36 equal monthly installments thereafter.
Filing Info
Litten Jason's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-01-02 | GNLX | A | $0 |
Other Insiders at GNLX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Yu Yong / Cappello Joseph
SVP, Clinical Development
|
— | $2K | 2026-03-24 |
|
Zindrick Thomas
President and CEO
|
— | $9K | 2026-03-24 |
| Thomas John | — | $29K | 2026-03-02 |
|
Smalling Ralph
Head of Regulatory
|
— | $1K | 2026-03-25 |